{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:11:28Z","timestamp":1761919888632},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.0814","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:28:43Z","timestamp":1413329323000},"page":"2377-2380","source":"Crossref","is-referenced-by-count":7,"title":["Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sj\u00f6gren's Syndrome Relapse Free Following Tacrolimus Treatment"],"prefix":"10.2169","volume":"53","author":[{"given":"Xueping","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Qingdao Women and Children Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenru","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol 20: 255-260, 2007.","DOI":"10.1097\/WCO.0b013e32814f1c6b"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815, 2007.","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kolfenbach JR, Horner BJ, Ferucci ED, West SG. Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis. Arthritis Care Res (Hoboken) 63: 1203-1208, 2011.","DOI":"10.1002\/acr.20486"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kahlenberg JM. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome. Semin Arthritis Rheum 40: 343-348, 2011.","DOI":"10.1016\/j.semarthrit.2010.05.005"},{"key":"5","unstructured":"5. Thomson AW, Carroll PB, McCauley J, et al. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol 14: 323-344, 1993."},{"key":"6","unstructured":"6. Ponseti JM, Gamez J, Azem J, López-Cano M, Vilallonga R, Armengol M. Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann N Y Acad Sci 1132: 254-263, 2008."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ishigaki K, Shishikura K, Murakami T, Suzuki H, Hirayama Y, Osawa M. Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis. Brain Dev 31: 634-637, 2009.","DOI":"10.1016\/j.braindev.2008.08.016"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Inamura N, Hashimoto M, Nakahara K, et al. Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats. Int J Immunopharmacol 10: 991-995, 1988.","DOI":"10.1016\/0192-0561(88)90046-X"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kageyama T, Komori M, Miyamoto K, et al. Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol 260: 627-634, 2013.","DOI":"10.1007\/s00415-012-6692-2"},{"key":"10","unstructured":"10. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14: 1157-1174, 2008."},{"key":"11","unstructured":"11. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558, 2002."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kolfenbach JR, Horner BJ, Ferucci ED, West SG. Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis. Arthritis Care Res (Hoboken) 63: 1203-1208, 2011.","DOI":"10.1002\/acr.20486"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78-83, 2008.","DOI":"10.1001\/archneurol.2007.17"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131: 3072-3080, 2008.","DOI":"10.1093\/brain\/awn240"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ozgocmen S, Gur A. Treatment of central nervous system involvement associated with primary Sjögren's syndrome. Curr Pharm Des 14: 1270-1273, 2008.","DOI":"10.2174\/138161208799316366"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yaguchi H, Sakushima K, Takahashi I, et al. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Intern Med 52: 969-972, 2013.","DOI":"10.2169\/internalmedicine.52.7885"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.0814\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:50:07Z","timestamp":1621446607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.0814\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":16,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.0814","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}